CoverageForm 410-K10-Q8-K13D13G13F

AFJK Aimei Health Technology Co., Ltd. - 8-K

Accession
0001493152-26-015512
2.039.01

Item 2.03 - Creation of a Direct Financial Obligation

387 words

Item
2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

Extension
of the Termination Date

An
aggregate of $34,330.96 (the “ Extension Payment ”) has been deposited into the trust account of Aimei Health
Technology Co., Ltd (the “ Company ”) for its public shareholders, representing the lessor of (i) $80,000 for all outstanding
public shares and (ii) $0.033 for each outstanding public share for each monthly extension, which enables the Company to further extend
the period of time it has to consummate its initial business combination by one month (the “ Extension ”) from
April 6, 2026 to May 6, 2026 (the “ Termination Date ”). The Extension is the seventeenth extension permitted
under the Amended and Restated Articles of Association of the Company currently in effect.

Promissory
Note

In
connection with the Extension, the Company issued, on April 7, 2026, an unsecured promissory note in the total principal amount
of $34,330.96 (the “ Promissory Note ”) to Aimei Health Ltd, a Cayman Islands exempted company (the “ Sponsor ”)
and United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands (“ United Hydrogen ,”
and together with the Sponsor, the “ Payees ”). The amount was equally divided between the Payees, with each
contributing $17,165.48, to fund the Extension Payment. The Promissory Note does not bear interest and the principal thereunder becomes
due and payable upon the date on which the Company consummates a business combination with United Hydrogen (the “ Business
Combination ”). The Payees have the right, but not the obligation, to convert the Promissory Note, in whole or in part,
into private units of the Company, at a price of $10.00 per unit, each consisting of one ordinary share and one right to receive one-fifth
(1/5) of one ordinary share of the Company, immediately prior to the consummation of the Business Combination, by providing the Company
with written notices of their intention to convert the Promissory Note at least two business days prior to the closing of the Business
Combination.

The
foregoing description of the Promissory Note is not complete and is qualified in its entirety by reference to the text of such document,
which is filed as Exhibit 10.1 hereto and which is incorporated herein by reference.

Item 9.01 - Financial Statements and Exhibits

43 words

Item
9.01 Exhibits.

(d)
Exhibits

Exhibit
No.

Description

10.1

Promissory
Note, dated April 7, 2026, by and among Aimei Health Technology Co., Ltd, Aimei Health Ltd, and United Hydrogen Group Inc.

104

Cover Page Interactive
Data File (embedded within the Inline XBRL document)